In 2013, different groups demonstrated that loss of SDHA protein expression by immunohistochemistry reliably predicts the presence of SDHA mutations in GIST and can, therefore, be used to select patients with SDH‐deficient GIST for further molecular analysis.19, 20. This evidence concerns the gene SDHB and gastrointestinal stromal tumor.